Pulmonary pharmacology and therapeutics

Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
Toru Arai, Yoshikazu Inoue

ERJ Open Research Jul 2022, 8 (3) 00242-2022; DOI: 10.1183/23120541.00242-2022
Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
Roberto Benoni, Silvia Panunzi, Veronica Batani, Francesca Moretti, Stefano Fuggini, Mattia Todesco, Gianenrico Senna, Albino Poli, Andrea Vianello, Marco Caminati

ERJ Open Research Jul 2022, 8 (3) 00670-2021; DOI: 10.1183/23120541.00670-2021
Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease
Theodore K. Marras, Mariam Hassan, Kevin C. Mange, Monika Ciesielska, Shilpa Dhar Murthy, Zhanna Jumadilova, Anjan Chatterjee

ERJ Open Research Jul 2022, 8 (3) 00623-2021; DOI: 10.1183/23120541.00623-2021
The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids
Francisco-Javier Gonzalez-Barcala, Juan-Jose Nieto-Fontarigo, Paula Mendez-Brea, Francisco-Javier Salgado

ERJ Open Research Apr 2022, 8 (2) 00179-2022; DOI: 10.1183/23120541.00179-2022
Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoring
Mengru Zhang, Kayleigh Brindle, Melanie Robinson, Debbie Ingram, Tanya Cavany, Alyn Morice

ERJ Open Research Apr 2022, 8 (2) 00031-2022; DOI: 10.1183/23120541.00031-2022
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
Ian D. Pavord, Roland Buhl, Monica Kraft, Charlene M. Prazma, Robert G. Price, Peter H. Howarth, Steven W. Yancey

ERJ Open Research Apr 2022, 8 (2) 00560-2021; DOI: 10.1183/23120541.00560-2021
Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids
Marjolein M. Ensinck, Liesbeth De Keersmaecker, Anabela S. Ramalho, Senne Cuyx, Stephanie Van Biervliet, Lieven Dupont, Frauke Christ, Zeger Debyser, François Vermeulen, Marianne S. Carlon

ERJ Open Research Apr 2022, 8 (2) 00716-2021; DOI: 10.1183/23120541.00716-2021
CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018
Emily E. Ricotta, D. Rebecca Prevots, Kenneth N. Olivier

ERJ Open Research Apr 2022, 8 (2) 00724-2021; DOI: 10.1183/23120541.00724-2021
Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review
Raja Dhar, Deepak Talwar, Sundeep Salvi, B.V. Muralimohan, Sagar Panchal, Saiprasad Patil, Sagar Bhagat, Nishtha Khatri, Hanmant Barkate

ERJ Open Research Jan 2022, 8 (1) 00556-2021; DOI: 10.1183/23120541.00556-2021
Inhaled anti-asthma therapies following hormone therapy in women: a nationwide cohort study
Erik Soeren Halvard Hansen, Kristian Aasbjerg, Amalie Lykkemark Moeller, Amani Meaidi, Elisabeth Juul Gade, Christian Torp-Pedersen, Vibeke Backer

ERJ Open Research Jan 2022, 8 (1) 00611-2021; DOI: 10.1183/23120541.00611-2021

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us